Thirteen different diagnostic labels were used to describe asthma in these patients, of whom 67 (54.9%) had just one label, 41 (33.6%) had two, 10 (8.2%) had three, two (1.6%) had four, and two (1.6%) patients had five labels. The commonest label was asthma in 89 (73.0% of patients), followed by wheezy bronchitis in 30 (24.6%), bronchial asthma in 17 (14.0%), asthmatic bronchitis in 12 (9.8%), wheezy tendency in nine (5.4%), and late onset asthma in seven (5.7%). Ninety-one patients (74.6%) had mild asthma, 22 (18.0%) had moderate asthma and nine (7.4%) had severe asthma. (See Table I for definitions). Seventy patients (57.4%) were considered to be atopic. Forty-eight (39.3%) indicated on the questionnaire that their attacks were precipitated by specific allergens of which house dust was the most common, followed by pollens, animal dander and house dust mite. Twenty-two patients (18.0%) had had skin testing and 21 (17.3%) had had immunotherapy. Other precipitating factors were found as indicated in Table II . Twelve patients (9.8%) had been admitted to hospital in the last year, three of whom had two admissions. Eight of these patients were on bronchodilators, sodium chromoglycate and/or inhaled steroids. Of the remaining four, three were children under seven years who were managed on oral or nebulised bronchodilators and one was a 49-year-old male who had had two admissions in the last year and was treated with short courses of steroids. He complained of continuous cough and frequent episodic wheeze and dyspnoea, yet had attended his general practitioner only once and was on salbutamol inhaler as required! Twenty-two patients (18.0%) had at some time been followed up in the hospital outpatient department for asthma. Twelve (9.8%) had obtained direct hospital admission without contacting their general practitioner. Peak flow rate was monitored at each attack in 17 patients (13.9 %), irregularly in 40 (37.8 %) and never in 43 (35.2%). It was not practical in 22 (18.0%). Of the 43 patients who had never had a peak flow rate measured, only three had a single vitalograph reading and this was to demonstrate reversibility. Five out of the 16 patients who had had 24 or more significant acute attacks in one year had regular monitoring, eight had irregular monitoring, two had none, and monitoring was not practical in one case. Of the 20 patients who took oral steroids intermittently or continuously, only five had regular monitoring, eight had irregular monitoring, five had none, and with two it was not practical. Of the five patients who had never had peak flow monitoring, one was on continuous oral steroids. Twenty-six patients (21.3 %) had vitalograph measurements carried out, which were mainly used for diagnostic purposes to demonstrate reversibility.
DISCUSSION
This audit of asthma patients is an example of the use of a microcomputer in practice to identify patients. One hundred and twenty-two asthmatics (3.9%) were identified in a practice of 3140 patients. Thirteen different diagnostic labels were used with up to five different labels used for a single patient. This indicates difficulty in labelling the asthmatic and some labels may have been chosen to avoid alarming the patient by the term 'asthma'. However, this can only lead to confusion and possible undertreatment, particularly in a group practice of several general practitioners. With good education and treatment, patients can only benefit from knowing their diagnosis. The British Thoracic Association also found that deaths were more likely in those with chronic persistent symptoms, or those who had had previous sudden or severe attacks and unstable patterns with variable peak flow rates. Delay in starting treatment was the single most important factor, due mostly to the patient not recognising the severity of the attack. In the present study inadequate monitoring using the peak flow meter and vitalograph was found. While the condition of the patient can be assessed clinically to some degree from the history and physical examination, an objective test is highly desirable.5 The peak flow meter gives the doctor a simple tool with which he can assess the patient's condition and the effectiveness of therapy.6
In well-motivated patients, peak flow rates could be used to monitor the patient's day-to-day condition at home, so that impending attacks can be treated before full development has occurred, as with diabetic patients who monitor their blood sugars. This, with clear guidelines, could overcome some of the problems that patients have in deciding when to seek help.
In conclusion, many asthmatics are receiving inadequate treatment due to both patient and doctor failure, with poor monitoring of their condition. Better use of inhalers, with regular peak flow rate monitoring by the general practitioner and possibly home monitoring by the patient, patient diaries and better patient education, may go some way in reducing asthma deaths and improving morbidity.
